Literature DB >> 26206651

Nonclinical Factors Associated with 30-Day Mortality after Lung Cancer Resection: An Analysis of 215,000 Patients Using the National Cancer Data Base.

John N Melvan1, Manu S Sancheti2, Theresa Gillespie3, Dana C Nickleach4, Yuan Liu5, Kristin Higgins6, Suresh Ramalingam7, Joseph Lipscomb5, Felix G Fernandez8.   

Abstract

BACKGROUND: Clinical variables associated with 30-day mortality after lung cancer surgery are well known. However, the effects of nonclinical factors, including insurance coverage, household income, education, type of treatment center, and area of residence, on short-term survival are less appreciated. We studied the National Cancer Data Base, a joint endeavor of the Commission on Cancer of the American College of Surgeons and the American Cancer Society, to identify disparities in 30-day mortality after lung cancer resection based on these nonclinical factors. STUDY
DESIGN: We performed a retrospective cohort analysis of patients undergoing lung cancer resection from 2003 to 2011 using the National Cancer Data Base. Data were analyzed using a multivariable logistic regression model to identify risk factors for 30-day mortality.
RESULTS: During our study period, 215,645 patients underwent lung cancer resection. We found that clinical variables, such as age, sex, comorbidity, cancer stage, preoperative radiation, extent of resection, positive surgical margins, and tumor size were associated with 30-day mortality after resection. Nonclinical factors, including living in lower-income neighborhoods with a lesser proportion of high school graduates, and receiving cancer care at a nonacademic medical center were also independently associated with increased 30-day postoperative mortality.
CONCLUSIONS: This study represents the largest analysis of 30-day mortality for lung cancer resection to date from a generalizable national cohort. Our results demonstrate that, in addition to known clinical risk factors, several nonclinical factors are associated with increased 30-day mortality after lung cancer resection. These disparities require additional investigation to improve lung cancer patient outcomes. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2015        PMID: 26206651      PMCID: PMC4514912          DOI: 10.1016/j.jamcollsurg.2015.03.056

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  37 in total

Review 1.  An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes.

Authors:  Christopher G Slatore; David H Au; Michael K Gould
Journal:  Am J Respir Crit Care Med       Date:  2010-11-01       Impact factor: 21.405

2.  Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.

Authors:  Hude Quan; Bing Li; Chantal M Couris; Kiyohide Fushimi; Patrick Graham; Phil Hider; Jean-Marie Januel; Vijaya Sundararajan
Journal:  Am J Epidemiol       Date:  2011-02-17       Impact factor: 4.897

3.  Who receives their complex cancer surgery at low-volume hospitals?

Authors:  Waddah B Al-Refaie; Binyam Muluneh; Wei Zhong; Helen M Parsons; Todd M Tuttle; Selwyn M Vickers; Elizabeth B Habermann
Journal:  J Am Coll Surg       Date:  2011-11-23       Impact factor: 6.113

4.  STS database risk models: predictors of mortality and major morbidity for lung cancer resection.

Authors:  Benjamin D Kozower; Shubin Sheng; Sean M O'Brien; Michael J Liptay; Christine L Lau; David R Jones; David M Shahian; Cameron D Wright
Journal:  Ann Thorac Surg       Date:  2010-09       Impact factor: 4.330

5.  Impact of laterality on early and late survival after pneumonectomy.

Authors:  Felix G Fernandez; Seth D Force; Allan Pickens; Patrick D Kilgo; Theresa Luu; Daniel L Miller
Journal:  Ann Thorac Surg       Date:  2011-07       Impact factor: 4.330

6.  The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database.

Authors:  Elizabeth M Ward; Stacey A Fedewa; Vilma Cokkinides; Katherine Virgo
Journal:  Cancer J       Date:  2010 Nov-Dec       Impact factor: 3.360

7.  Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database.

Authors:  S A Fedewa; C Lerro; D Chase; E M Ward
Journal:  Gynecol Oncol       Date:  2011-04-03       Impact factor: 5.482

8.  Thirty-day mortality underestimates the risk of early death after major resections for thoracic malignancies.

Authors:  Robert R McMillan; Alexandra Berger; Camelia S Sima; Feiran Lou; Joseph Dycoco; Valerie Rusch; Nabil P Rizk; David R Jones; James Huang
Journal:  Ann Thorac Surg       Date:  2014-09-08       Impact factor: 4.330

9.  Changing urbanization patterns in US lung cancer mortality, 1950-2007.

Authors:  Gopal K Singh; Mohammad Siahpush; Shanita D Williams
Journal:  J Community Health       Date:  2012-04

10.  The effect of regionalization on outcome in pulmonary lobectomy: a Canadian national study.

Authors:  Christian J Finley; Anna Bendzsak; George Tomlinson; Shaf Keshavjee; David R Urbach; Gail E Darling
Journal:  J Thorac Cardiovasc Surg       Date:  2010-10       Impact factor: 5.209

View more
  10 in total

1.  Surgical Outcomes for Early Stage Non-small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs.

Authors:  Yusef A Syed; William Stokes; Manali Rupji; Yuan Liu; Onkar Khullar; Nikhil Sebastian; Kristin Higgins; Jeffrey D Bradley; Walter J Curran; Suresh Ramalingam; James Taylor; Manu Sancheti; Felix Fernandez; Drew Moghanaki
Journal:  Chest       Date:  2021-11-14       Impact factor: 9.410

2.  It's more than just cancer biology: Health disparities in patients with pancreatic neuroendocrine tumors.

Authors:  Patrick W Underwood; Andrea N Riner; Dan Neal; Miles E Cameron; Anastasiya Yakovenko; Sushanth Reddy; John Bart Rose; Steven J Hughes; Jose G Trevino
Journal:  J Surg Oncol       Date:  2021-09-09       Impact factor: 2.885

3.  Accuracy of co-morbidity data in patients undergoing abdominal wall hernia repair: a retrospective study.

Authors:  S Hajibandeh; S Hajibandeh; R Deering; D McEleney; J Guirguis; S Dix; A Sreh; E Toner; A El Muntasar; A Kausar; G Sheikh; D OShea; A Shafiq; A Kelly; A Khan; D Arumugam; A Evans
Journal:  Hernia       Date:  2017-12-14       Impact factor: 4.739

4.  Impact of comorbidity burden on morbidity following thoracoscopic lobectomy: a propensity-matched analysis.

Authors:  Ruoyu Zhang; Thomas Kyriss; Jürgen Dippon; Sebastian Ciupa; Enole Boedeker; Godehard Friedel
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

5.  Clinical Stage of Cancer Affects Perioperative Mortality for Gastrointestinal Cancer Surgeries.

Authors:  John Bliton; Michael Parides; Peter Muscarella; John C McAuliffe; Katia Papalezova; Haejin In
Journal:  J Surg Res       Date:  2020-12-09       Impact factor: 2.192

6.  Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan.

Authors:  Wen-Chi Chou; Pei-Hung Chang; Chang-Hsien Lu; Keng-Hao Liu; Yu-Shin Hung; Chia-Yen Hung; Chien-Ting Liu; Kun-Yun Yeh; Yung-Chang Lin; Ta-Sen Yeh
Journal:  J Cancer       Date:  2016-04-28       Impact factor: 4.207

7.  Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study).

Authors:  Christos Chouaïd; Didier Debieuvre; Isabelle Durand-Zaleski; Jérôme Fernandes; Arnaud Scherpereel; Virginie Westeel; Cécile Blein; Anne-Françoise Gaudin; Nicolas Ozan; Soline Leblanc; Alexandre Vainchtock; Pierre Chauvin; François-Emery Cotté; Pierre-Jean Souquet
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

8.  Socioeconomic Differences and Lung Cancer Survival-Systematic Review and Meta-Analysis.

Authors:  Isabelle Finke; Gundula Behrens; Linda Weisser; Hermann Brenner; Lina Jansen
Journal:  Front Oncol       Date:  2018-11-27       Impact factor: 6.244

9.  The pattern of comorbidities in cancer patients in Lagos, South-Western Nigeria.

Authors:  Omolola Salako; Paul T Okediji; Muhammad Y Habeebu; Omolara A Fatiregun; Opeyemi M Awofeso; Kehinde S Okunade; Ifedayo A Odeniyi; Kahmil O Salawu; Evaristus O Oboh
Journal:  Ecancermedicalscience       Date:  2018-06-13

Review 10.  Updated Prognostic Factors in Localized NSCLC.

Authors:  Simon Garinet; Pascal Wang; Audrey Mansuet-Lupo; Ludovic Fournel; Marie Wislez; Hélène Blons
Journal:  Cancers (Basel)       Date:  2022-03-09       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.